• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Catholic Review

Catholic Review

Inspiring the Archdiocese of Baltimore

Menu
  • Home
  • News
        • Local News
        • World News
        • Vatican News
        • Obituaries
        • Featured Video
        • En Español
        • Sports News
        • Official Clergy Assignments
        • Schools News
  • Commentary
        • Contributors
          • Question Corner
          • George Weigel
          • Effie Caldarola
          • John Garvey
          • Father Ed Dougherty, M.M.
          • Guest Commentary
        • CR Columnists
          • Archbishop William E. Lori
          • Rita Buettner
          • Christopher Gunty
          • George Matysek Jr.
          • Father Joseph Breighner
          • Father Collin Poston
          • Robyn Barberry
          • Hanael Bianchi
          • Amen Columns
  • Entertainment
        • Events
        • Movie & Television Reviews
        • Arts & Culture
        • Books
        • Recipes
  • About Us
        • Contact Us
        • Our History
        • Meet Our Staff
        • Photos to own
        • Books/CDs/Prayer Cards
        • CR Media platforms
        • Electronic Edition
  • Advertising
  • Shop
        • Purchase Photos
        • Books/CDs/Prayer Cards
  • CR Radio
  • News Tips
  • Subscribe
A box of the RU-486 drug, known generically as mifepristone and by its brand name Mifeprex, is seen in an undated handout photo. The U.S. FDA has approved distributing of the abortion pill through retail pharmacies, a move that could transform the US abortion industry and poses new challenges to the church's pro-life ministry. (OSV News photo/courtesy Danco Laboratories)

FDA permits retail pharmacies to dispense abortion drugs, prompting criticism from Catholic, pro-life groups

January 5, 2023
By Kate Scanlon
OSV News
Filed Under: Feature, News, Respect Life, World News

WASHINGTON (OSV News) — The U.S. Food and Drug Administration will allow retail pharmacies to offer abortion pills in the United States for the first time, the agency announced Jan. 3, prompting criticism from Catholic and pro-life groups.

The Biden administration’s rule change comes in the wake of the Supreme Court’s decision last year in Dobbs v. Jackson Women’s Health Organization that struck down the 1973 Roe v. Wade decision, enabling many states to restrict abortion access.

The regulatory change permits the sale of mifepristone, the first of two drugs used in a chemical abortion, at retail pharmacies. The drug could previously only be dispensed by some mail-order pharmacies, or by some doctors or abortion centers.

The rule change ends a previous in-person requirement for its dispersal. The new FDA rules still require a prescription for the drugs, but will permit a wider range of pharmacies to stock and sell them.

Medication abortions are becoming a more common method of abortion, accounting for more than half of the abortions in the United States, according to the Guttmacher Institute, a research center relied on by the abortion industry and advocacy groups.

Some Catholic and other pro-life groups have expressed concern about the safety of the drug. In a document outlining its opposition to expanding access to the drug for abortions, the U.S. Conference of Catholic Bishops argued that the FDA rejects safeguards governing its use that are in place in other countries, noting that in Sweden, for example, a woman undergoing a medication abortion would be “supervised by the midwife for 4 to 6 hours at the outpatient clinic.”

The FDA has called mifepristone “safe when used as indicated and directed.”

In a statement, Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, said: “The Biden administration has once again proved that it values abortion industry profits over women’s safety and unborn children’s lives.”

“Abortion activists want to turn every post office and pharmacy into an abortion business, and the Biden FDA is a willing participant — even while studies show emergency rooms are being flooded with women suffering from serious, life-threatening complications caused by abortion drugs,” Dannenfelser said. “Chemical abortion pills can cause dangerous complications including hemorrhage and infection, and complications are more likely when pills are dispensed without medical screening or follow-up care.”

Dannenfelser said that some pro-life governors “understand this threat, which is why many states have enacted safeguards to protect women and their unborn children.”

“State lawmakers and Congress must stand as a bulwark against the Biden administration’s pro-abortion extremism,” Dannenfelser said. “We hope to see the FDA do its job to protect the lives of women and put an end to chemical abortions.”

Kate Scanlon is a National Reporter for OSV News covering Washington.

Read More Respect Life

Biden reiterates call to codify Roe v. Wade in State of the Union address

U.S. bishops’ religious liberty chairman: Proposed new rules on contraceptive mandate ‘disheartening’

Free childbirth or reduce cost of raising kids? Pro-life leaders mull proposal for Congress

Affordable child care key component of post-Roe response, advocates say

Prioritize federal funds for families to embrace life, not abortion, says U.S. bishops’ pro-life chair

After Biden comments, U.S. bishops say they have ‘united position’ on abortion

Copyright © 2023 OSV News

Print Print

Primary Sidebar

Kate Scanlon

Our Sunday Visitor is a Catholic publisher serving millions of Catholics globally through its publishing and communication services.

View all posts from this author

For the latest news delivered twice a week via email or text message, sign up to receive our free enewsletter.

| MOST POPULAR |

  • Religious leaders share vocation stories with Cockeysville students
  • Annapolis parish marks historic milestone
  • Archdiocese dispenses with meatless obligation for St. Patrick’s Day
  • Tuition at Catholic high schools in Baltimore archdiocese significantly lower than other area private schools
  • Movie Review: ‘Knock at the Cabin’

| Latest Local News |

‘I’m a survivor’: Parishioner finds strength in faith even after abuse

Sister Margarita Musquera, O.S.P., dies at 93.

Archdiocese dispenses with meatless obligation for St. Patrick’s Day

| Latest World News |

Pope Francis calls for solidarity with Turkey, Syria after earthquakes

Biden reiterates call to codify Roe v. Wade in State of the Union address

Pope repeats calls, prayers for peace and justice in Africa

| Catholic Review Radio |

CatholicReview · Catholic Review Radio

Footer

Our Vision

Real Life. Real Faith. 

Catholic Review Media communicates the Gospel and its impact on people’s lives in the Archdiocese of Baltimore and beyond.

Our Mission

Catholic Review Media provides intergenerational communications that inform, teach, inspire and engage Catholics and all of good will in the mission of Christ through diverse forms of media.

Contact

Catholic Review
320 Cathedral Street
Baltimore, MD 21201
443-524-3150
mail@CatholicReview.org

 

Social Media

  • Facebook
  • Instagram
  • Twitter
  • YouTube

Recent

  • ‘I’m a survivor’: Parishioner finds strength in faith even after abuse
  • Pope Francis calls for solidarity with Turkey, Syria after earthquakes
  • Biden reiterates call to codify Roe v. Wade in State of the Union address
  • Pope repeats calls, prayers for peace and justice in Africa
  • Catholic aid agencies launch emergency collections for quake victims in Turkey, Syria
  • Eagles fans bring faith to the field for the Super Bowl
  • Catholic marriage prep: We want the whole feast, please!
  • Sister Margarita Musquera, O.S.P., dies at 93.
  • Archdiocese dispenses with meatless obligation for St. Patrick’s Day

Search

Membership

Catholic Press Association of the United States and Canada

Maryland-Delaware-DC Press Association

The Associated Church Press

© 2023 CATHOLIC REVIEW MEDIA, ALL RIGHTS RESERVED